For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

The Fischer Lab Modified Fibroblasts Research

We use recombinant retrovirus vectors to genetically modify cells as a strategy of promoting survival of injured neurons and axon regeneration.

A retrovirus is a virus which has a genome consisting of two RNA molecules, which may or may not be identical to each other. It relies on the enzyme reverse transcriptase to perform reverse transcription of its genome from RNA to DNA, which can then be integrated into the host's genome with an integrase enzyme.

In our paradigm, we have used a retrovirus containing neurotrophic genes, either neurotrophin-3 (NT-3) or brain derived neurotrophic factor (BDNF) a marker gene, which allows us to track the genetically modified cells with various staining methods.

Genetic modification and grafting of fibroblasts into the injured spinal cord

Drexel Fischer Lab: Genetic modification and grafting of fibroblasts into the injured spinal cord

Using these methods, the comlete rescue of injured neurons in Clarke's Nucleus by genetically modified cells that express NT-3 and the ability of cells that express BDNF to rescue injured neurons in the Red Nucleus (Himes et. al., 2001), induce regeneration of rubrospinal axons and promote significant functional recovery (Liu et. al., 1999; Liu et. al. 2002).

Drexel Fischer Lab: C4 Partial Hemisection Injuries the Rubrospinal Tract

References

Transplants of cells genetically modified to express neurotrophin-3 rescue axotomized Clarke's nucleus neurons after spinal cord hemisection in adult rats (Abstract)
Himes BT1, Liu Y, Solowska JM, Snyder EY, Fischer I, Tessler A.
J Neurosci Res. 2001 Sep 15;65(6):549-64.

Transplants of cells genetically modified to express neurotrophin-3 rescue axotomized Clarke's nucleus neurons after spinal cord hemisection in adult rats (Full Report)
Himes BT, Liu Y, Snyder EY, Fischer I, Tessler A.
J. Neurosci. Res. 2001:65:549-564

Intraspinal delivery of neurotrophin-3 using neural stem cells genetically modified by recombinant retrovirus (Online Article)
Liu Y, Himes T, Solowska-Baird J, Moul J, Chow S, Tessler A, Snyder E, and Fischer I.
Experimental Neurology. 1999:158:9-26

Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons (Online Article)
Liu Y, Kim Y, Himes T, Chow S, Murray M, Tessler A, Fischer I.
J. Neuroscience. 1999:19:4370-4387

Intraspinal grafting of fibroblasts genetically modified by recombinant adenoviruses (Abstract)
Liu Y, Himes T, Moul J, Chow S, Jin H, Murray M, Tessler A, Fischer I.
NeuroReport. 1998:9:1075-1079

Encapsulation of genetically modified fibroblasts

Drexel Fischer Lab: Encapsulation of genetically modified fibroblasts

We have shown that the immune response of the host can be circumvented by encapsulating our genetically modified fibroblasts inside a semi-permeable alginate capsule. Normally, the immune response is one of the most limiting factors in cellular transplant therapies. In this system, however, with immune cells prohibited from entering the membrane, the genetically modified fibroblasts are able to survive and produce BDNF without immune suppression.

Reference

Grafting of encapsulated BDNF-producing fibroblasts into inured spinal cord without immune suppression in adult rats (Abstract)
Tobias CA, Dhoot NO, Wheatley MA, Tessler A, Murray M, Fischer I.
J. Neurotrauma. 2001:18:287-301

 
 Back to Top